← Back to Search

Brock String Therapy for Concussion

N/A
Recruiting
Led By Anthony P Kontos, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 12-20
ages 12-20
Must not have
History of traumatic brain injury with imaging findings or brain surgery
Vestibular disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury)
Awards & highlights
No Placebo-Only Group

Summary

This trial will help determine if Brock String therapy can improve clinical outcomes for people with concussion.

Who is the study for?
This trial is for athletes aged 12-20 who have had a concussion during organized sports in the last 48 hours and show a receded near point of convergence (NPC) greater than 10 centimeters. It's not suitable for those without smartphone access, with severe symptoms, recent concussions, vestibular or seizure disorders, significant brain injury history, intellectual disabilities, or substance abuse issues.
What is being tested?
The study tests if Brock String therapy helps improve NPC measurements and cognitive test scores post-concussion better than standard care. It also looks at whether this therapy can shorten the time it takes for injured athletes to return to play.
What are the potential side effects?
Brock String therapy is generally considered low-risk; however, individuals with severe concussion symptoms may not tolerate it well. The trial excludes these participants to minimize potential discomfort or adverse effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 20 years old.
Select...
I am between 12 and 20 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a brain injury or surgery confirmed by scans.
Select...
I have a balance disorder.
Select...
I have a seizure disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Near point of convergence measurement
Secondary study objectives
Immediate Post Concussion Assessment and Cognitive Testing (ImPACT
concussion recovery duration

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brock StringExperimental Treatment1 Intervention
Participants will receive instruction on Brock String therapy after first clinic visit (\<48 hours post) injury, and will complete home therapy exercise twice daily
Group II: Standard of CareActive Control1 Intervention
Participants will receive standard of care (i.e., no Brock String therapy within the first week post injury) but will be informed they will receive any therapy deemed necessary at follow up visit 7-10 days post injury, consistent with standard of care

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,787 Previous Clinical Trials
16,359,303 Total Patients Enrolled
Anthony P Kontos, PhDPrincipal InvestigatorUniversity of Pittsburgh
4 Previous Clinical Trials
237 Total Patients Enrolled
Alicia Trbovich, PhDPrincipal Investigator - University of Pittsburgh
University of Pittsburgh

Media Library

Brock String Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04076657 — N/A
Near Point Convergence Research Study Groups: Brock String, Standard of Care
Near Point Convergence Clinical Trial 2023: Brock String Therapy Highlights & Side Effects. Trial Name: NCT04076657 — N/A
Brock String Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04076657 — N/A
~10 spots leftby Nov 2025